SCHEMBL8765003

SCHEMBL8765003

COc1ccc(-c2c(C(F)F)nn(-c3ccccc3)c2-c2ccc(S(N)(=O)=O)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 14/20 0.56
▸ PTGS1 P23219 8/20 0.56
▸ ALDH1A1 P00352 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ CA1 P00915 2/20 0.46
▸ CA2 P00918 2/20 0.46
▸ CA9 Q16790 1/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8765934 0.97 PTGS2 (0.58) PTGS2PTGS1CA1CA2CA9
SCHEMBL8765335 0.95 PTGS2 (0.62) PTGS2PTGS1ALDH1A1CA1CA2
SCHEMBL8765201 0.91 PTGS1 (0.47) PTGS2PTGS1ALDH1A1LMNAHTT
SCHEMBL8765086 0.90 PTGS2 (0.54) PTGS2PTGS1CA1CA2CA9
Dimethylamine SCHEMBL8765256 0.88 PTGS2 (0.51) PTGS2PTGS1
SCHEMBL8765225 0.88 PTGS2 (0.54) PTGS2PTGS1LMNACA1CA2
SCHEMBL8920843 0.88 PTGS2 (0.48) PTGS2PTGS1ALDH1A1LMNAHTT
SCHEMBL8764778 0.87 PTGS2 (0.48) PTGS2PTGS1CA1CA2CA9
SCHEMBL8637420 0.87 PTGS2 (0.60) PTGS2PTGS1LMNANPSR1CA1
SCHEMBL27459433 0.87 PTGS2 (0.58) PTGS2PTGS1CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0731794-B1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS SEARLE & CO (US) 1997-08-06 — — EP disclosed
US-5639777-A 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders G.D. SEARLE & CO. (US) 1997-06-17 — — US disclosed
EP-0731794-A1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS SEARLE & CO (US) 1996-09-18 — — EP disclosed
WO-1995015317-A1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS G.D. SEARLE & CO. (US) 1995-06-08 — — WO disclosed
Send feedback